NCT00881400View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Healthy
Interventions
DRUG

Cefprozil 250 mg/5 ml Oral Suspension (Sandoz, Austria)

DRUG

Cefzil (Cefprozil) 250 mg/5 ml Oral Suspension (Bristol-Myers Squibb, USA)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY